The Diabetes Impact Project, supported by Eli Lilly and Company, has been a success in reducing diabetes rates in three ...

The suspended Temple University student spoke with several far-right media figures, including Stew Peters, Lilly Gaddis and ...

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...

The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...

A rapidly developed, dual-target chimeric antigen receptor T-cell therapy produced a 100% overall response rate in patients ...

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...

Rob Lowe opened up to PEOPLE about his late grandmother’s breast cancer journey and her success in a clinical trial. He’s now ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Trump shared the anecdote as he signed an order Monday intended to drastically reduce the price Americans pay for pharmaceutical products — without naming the friend he was talking about.

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.